Global optic nerve disorders treatment market to Surpass US$ 19.5 billion by 2027

 

The cranial nerves that connect the cells in the retina to the optic chiasm in the brain are known as optic nerves. The photoreceptor cells in the retina receive light and communicate it to the brain in the form of electric impulses via the optic nerves. Vision loss can result from damage or dysfunction to the optic nerves, depending on the type and location of the impairment. It is possible to lose eyesight in either one or both eyes. Glaucoma, optic neuritis, optic nerve atrophy, and Optic Disc Drusen (ODD) are all examples of optic nerve illnesses. Multiple factors can cause this, and treatment options include steroids, intravenous immune globulin (IVIG)/plasma exchange, vitamin B12 injections, surgery, and more, depending on the severity and kind of disease.

The market for optic nerve disorders treatment has been increasing at a faster rate with significant growth rates in recent years, and it is expected to grow moderately in the anticipated period, i.e. 2021 to 2028. By 2027, the global optic nerve disorders treatment market is predicted to grow at a CAGR of 4%, reaching a value of US$ 19.5 billion.

Increased demand for optic nerve disorder medications and operations has been propelled by the growing awareness of taking preventive steps for diagnosis to avoid further worsening of the ailment, which has fueled the growth of the Optic Nerve Disorders Treatment Market. The Global Optic Nerve Disorders Treatment Market study offers a comprehensive assessment of the industry. The research includes a detailed analysis of key segments, trends, drivers, constraints, the competitive landscape, and other important market variables. The Global Optic Nerve Disorders Treatment Market study offers a comprehensive assessment of the industry. The research includes a detailed analysis of key segments, trends, drivers, constraints, the competitive landscape, and other important market variables.

According to the World Health Organization, 2.2 billion people were affected by vision impairment or blindness in 2019. Cataracts, uncorrected refractive errors, glaucoma, corneal opacification, and other conditions are among the most common causes of vision impairment. Glaucoma is a common cause, and it is caused by an increase in fluid pressure in the eye, which affects the optic nerve.

It is frequently hereditary, but it can also be caused by infection, chemical eye injury, and other factors. It can be treated with eye drops, oral drugs, and operations such as laser therapy if caught early. Multiple sclerosis (MS) is an autoimmune illness in which the immune system attacks the body's healthy cells, resulting in optic neuritis. MS is growing more common.

Due to the adoption of a sedentary lifestyle, bad food, lack of physical activities, and other factors, lifestyle diseases such as diabetes, blood pressure, and hypertension is on the rise, which increases the risk of MS leading to optic neuritis. As a result, the number of people requiring treatment for the disease is increasing.

Steroids are commonly used to treat optic neuritis to prevent the condition from worsening. Even though optic nerve illnesses cannot be totally treated, there is a strong emphasis on preventing these diseases and detecting them early to reduce the complications associated with medication, medications, and surgery.

The market is divided into Eye Drops, Steroids, Intravenous immune globulin (IVIG)/Plasma Exchange, Vitamin B12 injection, and Surgery based on the type of treatment.

Glaucoma, Optic neuritis and Others are the three types of nerve disorders that the market is divided into.

The market is divided into three types of end-users: hospitals, ophthalmology clinics, and ambulatory surgical centres.